Bioequivalence and Drug - Drug Interaction Study of Metformin/Gliclazide in Healthy Participants

NCT03467945 PHASE1 COMPLETED Results posted

This study investigated the bioequivalence and drug-drug interaction of Metformin/Gliclazide fixed combination tablet compared to co-administration of individual tablets of Metformin and Gliclazide.

Details

Lead sponsor	Merck KGaA, Darmstadt, Germany
Phase	PHASE1
Status	COMPLETED
Enrolment	40
Start date	Fri Feb 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Apr 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Healthy

Interventions

• Metformin/Gliclazide Fixed Combination
• Metformin
• Gliclazide

Countries

Germany